Musclepharm Corporation
4400 Vanowen Street
Burbank, CA 91505
(303) 396-6100
January 10, 2018
Securities and Exchange CommissionOffice of Global Security Risk
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Cecilia Blye
Comment Letter Dated December 22, 2017
Musclepharm Corporation
Form 10-K for Fiscal Year Ended December 31, 2016
File No. 0-53166
Dear Ms. Blye:
Musclepharm Corporation (the “Company”) hereby submits a request for an extension to respond to the comment letter referenced above until January 22, 2018. Due to reduced resources available at the Company during the recent holiday break, the Company will require additional time to prepare its response.
If you have any questions relating to the foregoing, please contact the undersigned at (818) 658-3806.
Musclepharm Corporation
By: /s/ Kevin Harris                             
Name: Kevin Harris
Title: Interim Chief Financial Officer